Hugo Geerts
CSO
In-Silico Biosciences

Hugo Geerts has almost twenty years experience in drug discovery and development as a Research Fellow at the Janssen Research Foundation laboratoria in Beerse, Belgium. At Janssen he was involved in the successful development, launch and lifecycle management of galantamine (Reminyl, Razadyne) for Alzheimer’s disease.
Dr. Geerts has a bachelor’s degree in theoretical physics, a bachelor’s degree in medicine, a Ph.D. in biophysics from the University of Antwerp and a Pharmaceutical Executive MBA degree from Drexel’s Lebow College of Business in Philadelphia. Dr. Geerts is an Adjunct Professor in the School of Medicine at the University of Pennsylvania; he has more than sixty-five peer-reviewed publications; and he is inventor/co-inventor on twelve patents.